✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
圣和化工
首页 › 产品目录 › 布加替尼

布加替尼

CAS 1197953-54-0C29H39ClN7O2PMW 584.1

布加替尼,CAS 登记号 1197953-54-0,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于医药中间体及原料药。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。

规格参数

CAS号1197953-54-0
分子式C29H39ClN7O2P
分子量584.1
LogP5.17
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域医药中间体及原料药
类别医药中间体及原料药

用途与场景

医药中间体及原料药

包装与供货

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
供货周期现货/按订单安排

文件与支持

每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。

常见问题

在哪里能查到 布加替尼 的 CAS 号?

本页已列出 布加替尼 的 CAS 号:1197953-54-0,可与随货 COA 核对。

可以提供哪些规格和包装?

常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。

布加替尼 一般用在什么产品里?

主要涉及医药中间体及原料药。

下单流程是怎样的?

来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。

PubChem 公开数据

Description

Brigatinib · CAS 1197953-54-0 · C29H39ClN7O2P. UNII HYW8DB273J. LogP: 5.17.

Identification

CAS Registry Number1197953-54-0
PubChem CID68165256
Molecular formulaC29H39ClN7O2P
IUPAC name5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine
UNII (FDA)HYW8DB273J

Computed Descriptors

Molecular Weight584.1
XLogP34.6
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count9
Rotatable Bond Count8
Exact Mass583.2591382
Monoisotopic Mass583.2591382
Topological Polar Surface Area85.9
Heavy Atom Count40
Formal Charge0

Physical & Chemical Properties

LogP5.17

Physical description & handling notes

  • Insoluble

GHS Hazard Classification

Reported hazard statementsH301 (100%), H361 (100%), H372 (100%), H410 (100%)

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]

Documented Uses

  • Brigatinib is a tyrosine kinase receptor inhibitor and antineoplastic agent used in the therapy of selected forms of advanced non-small cell lung cancer. Brigatinib is associated with a moderate rate of transient elevations in serum aminotransferase levels during therapy but has yet to be linked to instances of clinically apparent acute liver injury.
  • Breast Feeding; Lactation; Antineoplastic Agents; Enzyme Inhibitors; Protein Kinase Inhibitors; Signal Transduction Inhibitors; Tyrosine Kinase Inhibitors;
  • Brigatinib is approved to treat:
  • • Non-small cell lung cancer that is ALK positive and has metastasized (spread to other parts of the body). It is used in adults.
  • Brigatinib is also being studied in the treatment of other types of cancer.
  • Avoid grapefruit products. Grapefruit inhibits CYP3A metabolism, which may increase the serum concentration of brigatinib.

Synonyms

Brigatinib; 1197953-54-0; ALUNBRIG; AP-26113; HYW8DB273J; DTXSID501027929; brigatinibum; RefChem:56949; L01XE43; DTXCID501513495; AP 26113; Brigatinib [USAN]; Brigatinib (AP-26113); MFCD29472221; Brigatinib (AP26113); NCGC00483924-01

Frequently Asked Questions

What are the CAS number and molecular formula of Brigatinib?

CAS 1197953-54-0; molecular formula C29H39ClN7O2P; molecular weight — g/mol.

What other names is Brigatinib known by?

Brigatinib, 1197953-54-0, ALUNBRIG, AP-26113, HYW8DB273J, DTXSID501027929.

Is Brigatinib classified as hazardous?

Hazard statements reported: H301, H361, H372, H410.

What are the key physical properties of Brigatinib?

LogP: 5.17.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

同类推荐

获取 布加替尼 报价

供应商:济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp
鲁ICP备19031700号-1